Prognostic impact of surgery and radiofrequency ablation on single nodular HCC ≤5 cm: Cohort study based on serum HCC markers

Journal of Hepatology

Volumn 63, Issue 6, 2015, Pages 1352-1359

  Ueno, Masaki ^a   Hayami, Shinya ^a   Shigekawa, Yoshinobu ^a   Kawai, Manabu ^a   Hirono, Seiko ^a   Okada, Ken Ichi ^a   Tamai, Hideyuki ^a   Shingaki, Naoki ^a   Mori, Yoshiyuki ^a   Ichinose, Masao ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Radiofrequency ablation; Surgery; Tumor marker

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; GADOXETIC ACID; LENS CULINARIS AGGLUTININ REACTIVE FRACTION OF ALPHA FETOPROTEIN; SERUM ALBUMIN; UNCLASSIFIED DRUG; AFP PROTEIN, HUMAN; BIOLOGICAL MARKER; LENTIL LECTIN; PLANT LECTIN; PROTEIN PRECURSOR; PROTHROMBIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CHILD PUGH SCORE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; MILD HEPATIC IMPAIRMENT; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SEROLOGY; BLOOD; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; KAPLAN MEIER METHOD; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; MORTALITY; PROGNOSIS; TUMOR RECURRENCE;

AGED; ALPHA-FETOPROTEINS; BIOMARKERS; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PLANT LECTINS; PROGNOSIS; PROTEIN PRECURSORS; PROTHROMBIN;

EID: 84951015402     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.07.013     Document Type: Article

References (45)

1. S.F. Altekruse, K.A. McGlynn, and M.E. Reichman Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005 J Clin Oncol 27 2009 1485 1491
2. S. Arii, Y. Yamaoka, S. Futagawa, K. Inoue, K. Kobayashi, M. Kojiro, and et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan Hepatology 32 2000 1224 1229
3. J.M. Llovet, and J. Bruix Novel advancements in the management of hepatocellular carcinoma in 2008 J Hepatol 48 2008 S20 S37
4. S. Rossi, M. Di Stasi, E. Buscarini, P. Quaretti, F. Garbagnati, L. Squassante, and et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer AJR Am J Roentgenol 167 1996 759 768
5. S. Shiina, T. Teratani, S. Obi, K. Hamamura, Y. Koike, and M. Omata Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation Oncology 62 2002 64 68
6. W.Y. Lau, and E.C. Lai The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review Ann Surg 249 2009 20 25
7. M.S. Chen, J.Q. Li, Y. Zheng, R.P. Guo, H.H. Liang, Y.Q. Zhang, and et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma Ann Surg 243 2006 321 328
8. T. Livraghi, F. Meloni, M. Di Stasi, E. Rolle, L. Solbiati, C. Tinelli, and et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 47 2008 82 89
9. G. N'Kontchou, A. Mahamoudi, M. Aout, N. Ganne-Carrie, V. Grando, E. Coderc, and et al. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis Hepatology 50 2009 1475 1483
10. Y.K. Cho, H. Rhim, and S. Noh Radiofrequency ablation versus surgical resection as primary treatment of hepatocellular carcinoma meeting the Milan criteria: a systematic review J Gastroenterol Hepatol 26 2011 1354 1360
11. M. Abu-Hilal, J.N. Primrose, A. Casaril, M.J. McPhail, N.W. Pearce, and N. Nicoli Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma J Gastrointest Surg 12 2008 1521 1526
12. J. Huang, L. Yan, Z. Cheng, H. Wu, L. Du, J. Wang, and et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria Ann Surg 252 2010 903 912
13. K. Hasegawa, N. Kokudo, M. Makuuchi, N. Izumi, T. Ichida, M. Kudo, and et al. Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey J Hepatol 58 2013 724 729
14. S. Kiriyama, K. Uchiyama, M. Ueno, S. Ozawa, S. Hayami, M. Tani, and et al. Triple positive tumor markers for hepatocellular carcinoma are useful predictors of poor survival Ann Surg 254 2011 984 991
15. H. Miyaaki, O. Nakashima, M. Kurogi, K. Eguchi, and M. Kojiro Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma J Gastroenterol 42 2007 962 968
16. R.T. Poon, C. Lau, R. Pang, K.K. Ng, J. Yuen, and S.T. Fan High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies Ann Surg Oncol 14 2007 1835 1845
17. R. Tateishi, S. Shiina, H. Yoshida, T. Teratani, S. Obi, N. Yamashiki, and et al. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers Hepatology 44 2006 1518 1527
18. H. Oka, A. Tamori, T. Kuroki, K. Kobayashi, and S. Yamamoto Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma Hepatology 19 1994 61 66
19. Y. Mita, Y. Aoyagi, M. Yanagi, T. Suda, Y. Suzuki, and H. Asakura The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma Cancer 82 1998 1643 1648
20. F. Nomura, M. Ishijima, K. Kuwa, N. Tanaka, T. Nakai, and K. Ohnishi Serum des-gamma-carboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma Am J Gastroenterol 94 1999 650 654
21. Y. Shimauchi, M. Tanaka, R. Kuromatsu, R. Ogata, Y. Tateishi, S. Itano, and et al. A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients Oncol Rep 7 2000 249 256
22. K. Shirai, H. Tamai, N. Shingaki, Y. Mori, K. Moribata, S. Enomoto, and et al. Clinical features and risk factors of extrahepatic seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma Hepatol Res 41 2011 738 745
23. Y. Mori, H. Tamai, N. Shingaki, K. Moribata, H. Deguchi, K. Ueda, and et al. Signal intensity of small hepatocellular carcinoma on apparent diffusion coefficient mapping and outcome after radiofrequency ablation Hepatol Res 45 2015 75 87
24. S. Saito, J. Yamanaka, K. Miura, N. Nakao, T. Nagao, T. Sugimoto, and et al. A novel 3D hepatectomy simulation based on liver circulation: application to liver resection and transplantation Hepatology 41 2005 1297 1304
25. K. Uchiyama, K. Mori, K. Tabuse, M. Ueno, S. Ozawa, T. Nakase, and et al. Assessment of liver function for successful hepatectomy in patients with hepatocellular carcinoma with impaired hepatic function J Hepatobiliary Pancreat Surg 15 2008 596 602
26. M. Ueno, K. Uchiyama, S. Ozawa, S. Hayami, S. Kiriyama, and H. Yamaue A new prediction model of postoperative complications after major hepatectomy for hepatocellular carcinoma Dig Surg 26 2009 392 399
27. S. Eguchi, T. Kanematsu, S. Arii, M. Okazaki, K. Okita, M. Omata, and et al. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey Surgery 143 2008 469 475
28. K.S. Ahn, K.J. Kang, T.J. Park, Y.H. Kim, T.J. Lim, and J.H. Kwon Benefit of systematic segmentectomy of the hepatocellular carcinoma: revisiting the dye injection method for various portal vein branches Ann Surg 258 2013 1014 1021
29. K. Feng, J. Yan, X. Li, F. Xia, K. Ma, S. Wang, and et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma J Hepatol 57 2012 794 802
30. J.Y. Ni, L.F. Xu, H.L. Sun, J.X. Zhou, Y.T. Chen, and J.H. Luo Percutaneous ablation therapy versus surgical resection in the treatment for early-stage hepatocellular carcinoma: a meta-analysis of 21,494 patients J Cancer Res Clin Oncol 139 2013 2021 2033
31. Y. Mori, H. Tamai, N. Shingaki, K. Moribata, T. Shiraki, H. Deguchi, and et al. Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma Hepatol Int 3 2009 509 515
32. M. Kudo Local ablation therapy for hepatocellular carcinoma: current status and future perspectives J Gastroenterol 39 2004 205 214
33. M. Kono, T. Inoue, M. Kudo, H. Chishina, T. Arizumi, M. Takita, and et al. Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence Digest Dis 32 2014 670 677
34. B.Q. Cheng, C.Q. Jia, C.T. Liu, W. Fan, Q.L. Wang, Z.L. Zhang, and et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial JAMA 299 2008 1669 1677
35. K. Hasegawa, N. Kokudo, H. Imamura, Y. Matsuyama, T. Aoki, M. Minagawa, and et al. Prognostic impact of anatomic resection for hepatocellular carcinoma Ann Surg 242 2005 252 259
36. S. Agrawal, and J. Belghiti Oncologic resection for malignant tumors of the liver Ann Surg 253 2011 656 665
37. H. Tranchart, M. Chirica, A. Sepulveda, P.P. Massault, F. Conti, O. Scatton, and et al. Long-term outcomes following aggressive management of recurrent hepatocellular carcinoma after upfront liver resection World J Surg 36 2012 2684 2691
38. K.K. Ng, R.T. Poon, C.M. Lo, J. Yuen, W.K. Tso, and S.T. Fan Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma J Gastrointest Surg 12 2008 183 191
39. M. Kobayashi, K. Ikeda, Y. Kawamura, H. Yatsuji, T. Hosaka, H. Sezaki, and et al. High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma Cancer 115 2009 571 580
40. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators Hepatology 28 1998 751 755
41. R. Fox, S. Berhane, M. Teng, T. Cox, T. Tada, H. Toyoda, and et al. Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model Br J Cancer 110 2014 2090 2098
42. T. Kumada, H. Toyoda, T. Tada, S. Kiriyama, M. Tanikawa, Y. Hisanaga, and et al. High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma J Gastroenterol 49 2014 555 563
43. R. Yamaguchi, H. Yano, A. Iemura, S. Ogasawara, M. Haramaki, and M. Kojiro Expression of vascular endothelial growth factor in human hepatocellular carcinoma Hepatology 28 1998 68 77
44. A. Diaz-Sanchez, A. Matilla, O. Nunez, R. Lorente, A. Fernandez, D. Rincon, and et al. Serum angiopoietin-2 level as a predictor of tumor invasiveness in patients with hepatocellular carcinoma Scand J Gastroenterol 48 2013 334 343
45. M. Capurro, I.R. Wanless, M. Sherman, G. Deboer, W. Shi, E. Miyoshi, and et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma Gastroenterology 125 2003 89 97